← Leaderboards
William Owen Osburn
Johns Hopkins University
$3,880,034
Attributed
$4,546,744
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,546,744 · 3
By mechanism
U54$2,968,042 · 1
R01$1,333,420 · 1
R21$245,282 · 1
Top collaborators
- Charles J Lowenstein2 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Janice Ellen Clements$36,709,994
- David L Thomas$44,227,388
- Andrea L Cox$41,369,991
- Robert F Siliciano$70,514,274
- Gregory D Kirk$60,349,977
Others in their field
Other Emerging Leaders on “Innovation”
- Klaus Romero · Critical Path Institute$86,053,372
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,439,892
- Ted Ross · University Of Georgia$70,992,558
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$69,953,681
- Tony Moody · Duke University$65,625,959
- Matthew Johnson · Duke University$60,590,296
Research focus
InnovationDetectionSamplingSuccessDevicesDiagnostic PlatformDiagnostic StrategyCovid-19 DetectionDesignCovid-19 Point Of Care2019-NcovAwardAffectDiagnosticCommercializationCommunitiesClinical Laboratory Improvement AmendmentsCommunicable DiseasesCostCovid-19 AssayCovid-19 DiagnosticCovid-19 PandemicAdoptionAcceleration
Grant awards (6)
Technology Core$859,747
U54 · FY2025 · EB · contact PI
BCOR Regulation of Venous Thromboembolism$666,710
R01 · FY2025 · HL
Technology Core$1,182,807
U54 · FY2024 · EB · contact PI
BCOR Regulation of Venous Thromboembolism$666,710
R01 · FY2024 · HL
Technology Core$925,488
U54 · FY2023 · EB · contact PI
Immune correlates of HAART-mediated spontaneous control of chronic HCV infection$245,282
R21 · FY2017 · AI · contact PI